0001415889-24-020551.txt : 20240801
0001415889-24-020551.hdr.sgml : 20240801
20240801183433
ACCESSION NUMBER: 0001415889-24-020551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240731
FILED AS OF DATE: 20240801
DATE AS OF CHANGE: 20240801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bowron Kimberly T
CENTRAL INDEX KEY: 0001866673
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35073
FILM NUMBER: 241168320
MAIL ADDRESS:
STREET 1: C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH
STREET 2: BUILDING C, SUITE 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gevo, Inc.
CENTRAL INDEX KEY: 0001392380
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 870747704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C
STREET 2: Suite 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: 303-858-8358
MAIL ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C
STREET 2: Suite 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: Gevo Inc
DATE OF NAME CHANGE: 20070307
4
1
form4-08012024_100829.xml
X0508
4
2024-07-31
0001392380
Gevo, Inc.
GEVO
0001866673
Bowron Kimberly T
C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH
BUILDING C, SUITE 310
ENGLEWOOD
CO
80112
false
true
false
false
Chief People Officer
1
Common Stock
2024-07-31
4
S
0
10598
0.5897
D
435223
D
Common Stock
17067.43
I
By 401(k) Plan
Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 25, 2024.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5800 to $0.5995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ E. Cabell Massey, Attorney-in-Fact
2024-08-01